CVE:MPH

Medicure Stock Forecast, Price & News

C$0.97

-0.03 (-3.00 %)

(As of 10/18/2021 11:08 AM ET)

Add

Compare

Today's Range

C$0.97

▼

C$0.97

50-Day Range

C$0.92

▼

C$1.20

52-Week Range

C$0.70

▼

C$2.01

Volume500 shs

Average Volume8,231 shs

Market CapitalizationC$9.94 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive MPH News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

About Medicure

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia; and ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure, as well as Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. The company was founded in 1997 and is headquartered in Winnipeg, Canada.

Apple Revenue Soars 54% In Q2 On Favorable Covid Comparisons; Profit Smashes Wall Street Forecasts
April 30, 2021 | ca.finance.yahoo.com

British athletes urged to follow Keely Hodgkinson’s example and to show no fear
March 10, 2021 | ca.finance.yahoo.com

Tesla loses a third of its value for the third time in a year
March 10, 2021 | sg.finance.yahoo.com

Priyanka Chopra announces new project happening this month
March 10, 2021 | sg.finance.yahoo.com

Oprah Wore a Super Rare Pair of Glasses During the Meghan and Harry Interview — but We Found 7 Near-Perfect Dupes
March 10, 2021 | ca.finance.yahoo.com

Gland Pharma Ltd
November 21, 2020 | reuters.com

Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports
August 24, 2020 | benzinga.com

Medicure Announces Normal Course Issuer Bid
June 29, 2020 | finance.yahoo.com

Health-Care Issues Prove Robust on Final Monday of June
June 29, 2020 | www.baystreet.ca

Medicure Q1 2020 results and conference call dates
May 6, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: CVE
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: CVE:MPH
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.medicure.com
Phone: +1-204-4877412
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: C$15.95 million
Price / Sales: 0.62
Cash Flow: C$0.24 per share
Price / Cash Flow: 4.04
Book Value: C$1.68 per share
Price / Book: 0.58

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 7.51
Current Ratio: 1.27
Quick Ratio: 0.69

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 10,251,000
Market Cap: C$9.94 million
Next Earnings Date: 11/10/2021 (Estimated)
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

1.13 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Medicure.

5.0 Community Rank

Outperform Votes
Medicure has received 111 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Medicure has received 37 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Medicure has received 75.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Medicure and other stocks. Vote “Outperform” if you believe MPH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MPH will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Medicure does not currently pay a dividend.
Dividend Growth
Medicure does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Medicure insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Medicure is -1.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Medicure is -1.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Medicure has a P/B Ratio of 0.58. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Medicure (CVE:MPH) Frequently Asked Questions

What stocks does MarketBeat like better than Medicure?: Wall Street analysts have given Medicure a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medicure wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
When is Medicure's next earnings date?: Medicure is scheduled to release its next quarterly earnings announcement on Wednesday, November 10th 2021.
View our earnings forecast for Medicure.
How were Medicure's earnings last quarter?: Medicure Inc. (CVE:MPH) issued its earnings results on Friday, August, 27th. The company reported ($0.06) earnings per share (EPS) for the quarter. The firm had revenue of $5.09 million for the quarter.
View Medicure's earnings history.
How has Medicure's stock been impacted by COVID-19?: Medicure's stock was trading at C$2.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MPH stock has decreased by 51.5% and is now trading at C$0.97.
View which stocks have been most impacted by COVID-19.
Who are Medicure's key executives?: Medicure's management team includes the following people:
Dr. Albert David Friesen, Founder, CEO & Chairman of the board (Age 74, Pay $330.75k)
Dr. Neil Owens Ph.D., Pres & COO
Mr. David Aaron Gurvey B.Sc., CMA, CPA, Chief Financial Officer (Age 55)
Dr. Reuben Saba Ph.D., VP of Scientific & Medical Affairs
Ms. Jamie Gowryluk, VP of Commercial Operations
Who are some of Medicure's key competitors?: Some companies that are related to Medicure include Devonian Health Group (GSD), Rua Life Sciences (RUA), ValiRx (VAL), Fusion Antibodies (FAB), Collagen Solutions plc (COS.L) (COS), NetScientific (NSCI), Liberty Biopharma (LTY), AorTech International (AOR), Hemogenyx Pharmaceuticals (HEMO), ImmuPharma (IMM), Bioasis Technologies (BTI), Kane Biotech (KNE), Sigyn Therapeutics (SIGY), Midatech Pharma (MTPH) and Crescita Therapeutics (CTX).
View all of MPH's competitors.
What other stocks do shareholders of Medicure own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Medicure investors own include Dollarama (DOL), Alimentation Couche-Tard (ATD.B), Canoe EIT Income Fund (ENDTF), ProMetic Life Sciences (PLI), Hudbay Minerals (HBM), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Detour Gold (DGC), Sinovac Biotech (SVA) and Viking Therapeutics (VKTX).
What is Medicure's stock symbol?: Medicure trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MPH."
How do I buy shares of Medicure?: Shares of MPH and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is Medicure's stock price today?: One share of MPH stock can currently be purchased for approximately C$0.97.
How much money does Medicure make?: Medicure has a market capitalization of C$9.94 million and generates C$15.95 million in revenue each year.
What is Medicure's official website?: The official website for Medicure is www.medicure.com.
Where are Medicure's headquarters?: Medicure is headquartered at 1250 Waverley St Suite 2, WINNIPEG, MB R3T 6C6, Canada.
How can I contact Medicure?: Medicure's mailing address is 1250 Waverley St Suite 2, WINNIPEG, MB R3T 6C6, Canada. The company can be reached via phone at +1-204-4877412.

This page was last updated on 10/19/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Medicure Stock Forecast, Price & News

About Medicure

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

5.0 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market

Price to Earnings Ratio vs. Sector

Price to Book Value per Share Ratio

Medicure (CVE:MPH) Frequently Asked Questions

What stocks does MarketBeat like better than Medicure?

When is Medicure's next earnings date?

How were Medicure's earnings last quarter?

How has Medicure's stock been impacted by COVID-19?

Who are Medicure's key executives?

Who are some of Medicure's key competitors?

What other stocks do shareholders of Medicure own?

What is Medicure's stock symbol?

How do I buy shares of Medicure?

What is Medicure's stock price today?

How much money does Medicure make?

What is Medicure's official website?

Where are Medicure's headquarters?

How can I contact Medicure?